z-logo
open-access-imgOpen Access
Male breast cancer diagnosis stages, treatment and survival in Uruguay: a retrospective analysis of a case series
Author(s) -
Natalia Camejo,
Cecilia Castillo,
Andrea Schiavone,
Ana Laura Alfonso,
Dahiana Amarillo,
Franco Xavier,
E. Álvarez,
Gabriel Krygier,
Lucı́a Delgado
Publication year - 2021
Publication title -
breast cancer management
Language(s) - English
Resource type - Journals
eISSN - 1758-1931
pISSN - 1758-1923
DOI - 10.2217/bmt-2020-0035
Subject(s) - medicine , male breast cancer , breast cancer , tamoxifen , stage (stratigraphy) , oncology , radiation therapy , chemotherapy , cancer , retrospective cohort study , disease , adjuvant chemotherapy , adjuvant , gynecology , paleontology , biology
Male breast cancer (MBC) is a rare condition which, while sharing some similarities with breast cancer in women, has a unique disease profile of its own. Aim: To understand the characteristics of MBC and its management in Uruguay. Patients & methods: Retrospective observational study that included patients diagnosed with MBC. Results: 22 cases of MBC were found. The median age at diagnosis was 62.5 years. Symptoms included self-detected lump in 17 patients (77.3%) and nipple retraction in seven (22.7%). Ductal carcinomas of histological grade 2–3 were found in 20 patients (90.9%) and stage I–II disease was most commonly encountered (15 patients, 68.1%). Neoadjuvant chemotherapy, adjuvant chemotherapy, adjuvant radiotherapy and tamoxifen were offered to 16 (73%), 12 (54.5%), 17 (65.4%) and 20 (90.9%) patients, respectively. Conclusion: MBC behaves and is treated in many aspects like postmenopausal breast cancer. Further multi-institutional, prospective studies are needed for better understanding and management of male breast cancers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here